Pharmaceutical Industry Information Portal

HomePharma marketing analytics

Pharma marketing analytics

Hikma Pharmaceuticals down 30%, stock to buy on fall

Hikma Pharmaceuticals is one of the biggest UK biotech stocks, only trailing giants like AstraZeneca and GlaxoSmithKline. Hikma was founded in 1978. Over the...

Pfizer, BioNTech shares rise after FDA approves Covid boosters for children

Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster...

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by a low-to-mid twenties percentage, but...

Novo Nordisk raises 2022 outlook after strong quarter, shares up

Novo Nordisk targets higher sales and operating profit for the year on the back of projected profit growth in the first quarter thanks to...

GSK shows strong sales performance in the first quarter of 2022 – £9.8 billion

British pharmaceutical giant GSK (GSK.L) on Wednesday beat analysts' expectations for its first-quarter results and reaffirmed its 2022 forecast. Highlights Strong sales growth across Biopharma and...

STADA continues to outpace the market in H1 and strengthens basis for further growth

STADA again demonstrated its resilience amid challenging conditions due to the pandemic by outperforming industry trends in the first half of 2021.

Expert Articles